Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09NXU
|
||||
| Former ID |
DNC012644
|
||||
| Drug Name |
4-(2,3-Dihydro-1H-phenalen-1-yl)-1H-imidazole
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [534160] | ||
| Formula |
C16H14N2
|
||||
| Canonical SMILES |
C1CC2=CC=CC3=C2C(=CC=C3)C1C4=CN=CN4
|
||||
| InChI |
1S/C16H14N2/c1-3-11-5-2-6-14-13(15-9-17-10-18-15)8-7-12(4-1)16(11)14/h1-6,9-10,13H,7-8H2,(H,17,18)
|
||||
| InChIKey |
KFGFWNKBPWPCKX-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Alpha-1B adrenergic receptor | Target Info | Inhibitor | [534160] | |
| Alpha-1D adrenergic receptor | Target Info | Inhibitor | [534160] | ||
| Alpha-1A adrenergic receptor | Target Info | Inhibitor | [534160] | ||
| NetPath Pathway | IL2 Signaling PathwayNetPath_14:IL2 Signaling Pathway | ||||
| Pathway Interaction Database | LPA receptor mediated events | ||||
| WikiPathways | Monoamine GPCRs | ||||
| Calcium Regulation in the Cardiac Cell | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| Vitamin D Receptor Pathway | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| AMPK SignalingWP58:Monoamine GPCRs | |||||
| GPCRs, OtherWP58:Monoamine GPCRs | |||||
| Endothelin Pathways | |||||
| AMPK Signaling | |||||
| References | |||||